PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+4.58%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$663M
AUM Growth
+$663M
(+5.5%)
Cap. Flow
+$163K
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
47.41%
Holding
224
New
41
Increased
20
Reduced
31
Closed
32
Top Buys
| 1 |
United Therapeutics
UTHR
|
$13.5M |
| 2 |
Cytokinetics
CYTK
|
$12.6M |
| 3 |
Illumina
ILMN
|
$10.5M |
| 4 |
ICU Medical
ICUI
|
$9.41M |
| 5 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
$7.52M |
Top Sells
| 1 |
Biogen
BIIB
|
$25.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 3 |
Pulmonx
LUNG
|
$9.13M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$9.01M |
| 5 |
Evolent Health
EVH
|
$7.06M |
Sector Composition
| 1 | Healthcare | 90.69% |
| 2 | Industrials | 0.83% |
| 3 | Materials | 0.39% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Biogen
BIIB
$20.5B
| $1.34M | 0.08% |
5,000
-96,711
| -95% | -$25.8M |
|
77
Exelixis
EXEL
$9.95B
| $1.18M | 0.07% |
75,000
| – | – |
|
78
Geron
GERN
$893M
| $1.17M | 0.07% |
+500,000
| New | +$1.17M |
|
|
CERE
79
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.16M | 0.07% |
+41,136
| New | +$1.16M |
|
80
Alkermes
ALKS
$4.95B
| $1.12M | 0.06% |
+50,000
| New | +$1.12M |
|
|
SONX
81
DELISTED
Sonendo, Inc.
SONX
| $1.1M | 0.06% |
1,023,424
| – | – |
|
|
VRNA
82
Verona Pharma
VRNA
$9.18B
| $1.02M | 0.06% |
+100,000
| New | +$1.02M |
|
|
QTNT
83
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $919K | 0.05% |
153,162
-13,388
| -8% | -$80.3K |
|
84
908 Devices
MASS
$214M
| $914K | 0.05% |
55,556
-240,732
| -81% | -$3.96M |
|
85
Eli Lilly
LLY
$661B
| $856K | 0.05% |
+2,646
| New | +$856K |
|
86
Verastem
VSTM
$585M
| $854K | 0.05% |
83,689
| – | – |
|
87
Rocket Pharmaceuticals
RCKT
$358M
| $798K | 0.05% |
+50,000
| New | +$798K |
|
|
HZNP
88
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $798K | 0.05% |
12,900
| – | – |
|
|
AGTI
89
DELISTED
Agiliti, Inc.
AGTI
| $704K | 0.04% |
+49,200
| New | +$704K |
|
|
MDVL
90
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $554K | 0.03% |
14,282
| – | – |
|
|
BLUE
91
DELISTED
bluebird bio
BLUE
| $504K | 0.03% |
+3,980
| New | +$504K |
|
92
Qiagen
QGEN
$10.1B
| $454K | 0.03% |
+10,374
| New | +$454K |
|
|
AVDL
93
Avadel Pharmaceuticals
AVDL
$1.45B
| $430K | 0.02% |
85,758
-703,423
| -89% | -$3.53M |
|
94
Athira Pharma
ATHA
$15.5M
| $416K | 0.02% |
139,924
-128,207
| -48% | -$381K |
|
95
Avidity Biosciences
RNA
$6.12B
| $302K | 0.02% |
+18,506
| New | +$302K |
|
96
Standard BioTools
LAB
$493M
| $278K | 0.02% |
253,132
-596,868
| -70% | -$656K |
|
97
MacroGenics
MGNX
$121M
| $182K | 0.01% |
+52,573
| New | +$182K |
|
98
Greenwich LifeSciences
GLSI
$157M
| $179K | 0.01% |
+19,667
| New | +$179K |
|
99
Quanterix
QTRX
$202M
| $156K | 0.01% |
14,200
-423,300
| -97% | -$4.65M |
|
|
RCOR
100
DELISTED
Renovacor, Inc.
RCOR
| $150K | 0.01% |
59,352
-85,573
| -59% | -$216K |
|